Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Hinyokika Kiyo. Acta Urologica Japonica|November 14, 2014
[A case of bladder cancer arising after augmentation cystoplasty using ileal patch for interstitial cystitis]Jinpei Kumagai, Hisashi Matsushima, Shinichiro Murayama, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 15, 2005
[A case of prostatic cystadenoma]Hirohito Kobayashi, Jinpei Kumagai, Shunichi Ono, et al.International Journal of Cancer|February 13, 2007
Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancerTetsuya Fujimura, Satoru Takahashi, Tomohiko Urano, et al.Cancer Research|May 4, 2005
Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinomaTetsuo Ogushi, Satoru Takahashi, Takumi Takeuchi, et al.Biochemical and Biophysical Research Communications|June 9, 2004
14-3-3sigma is down-regulated in human prostate cancerTomohiko Urano, Satoru Takahashi, Takashi Suzuki, et al.International Journal of Cancer|November 26, 2008
EBAG9 is a tumor-promoting and prognostic factor for bladder cancerJinpei Kumagai, Tomohiko Urano, Tetsuo Ogushi, et al.The Prostate|April 25, 2007
Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancerJinpei Kumagai, Tetsuya Fujimura, Satoru Takahashi, et al.The Prostate|September 3, 2013
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesisJinpei Kumagai, Johannes Hofland, Sigrun Erkens-Schulze, et al.International Journal of Cancer|March 10, 2011
Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancerDaisuke Obinata, Ken-ichi Takayama, Tomohiko Urano, et al.Urology|June 9, 2009
Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancerTetsuya Fujimura, Satoru Takahashi, Tomohiko Urano, et al.Pageof 2